Veracyte VCYT 深 滬
等待開盤 09-20 09:30:00 美东时间
35.25
+1.490
+4.41%
華盛通- 最 高35.51
- 今 開34.84
- 成交量 68.25万股
- 最 低 33.86
- 昨 收 33.76
- 總市值 26.46亿
- 52周最高 35.51
- 市盈率 靜 --
- 換手率 0.91%
- 52周最低 18.61
- 委 比 99.69%
- 總股本 7506.78万
- 歷史最高 86.03
- 量 比 0.80
- 振 幅 4.89%
- 歷史最低 4.21
- 每 手 1
- 風險率 3.50%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cathie Wood's Monday Maneuvers: Ark Invest Continues To Offload Robinhood And Palantir Shares
On Monday, Cathie Wood-led Ark Invest made significant trades, with Robinhood Markets Inc (NASDAQ:HOOD) and Palantir Technologies Inc (NYSE:PLTR) being the most prominent.
09-17 10:36
Veracyte Announces Expansion of Board with New Appointees
An update from Veracyte (VCYT) is now available. Veracyte, Inc. has expanded it...
09-05 04:28
快讯 | veracyte任命Brent Shafer和Tom Miller，博士，加入董事会
Veracyte Appoints Brent Shafer and Tom Miller, Ph.d., to Its Board of Directors
09-05 04:05
Enhanced Financial Outlook for Veracyte Following Shift to Non-GAAP Reporting Metrics
In a report released today, Michael Matson from Needham maintained a Buy rating...
08-28 17:25
Veracyte, Inc. (NASDAQ:VCYT) Is About To Turn The Corner
With the business potentially at an important milestone, we thought we'd take a...
08-14 19:46
恩佐生化盘中异动 大幅拉升5.24%
北京时间2024年08月14日02时12分，恩佐生化（ENZ.us）股票出现波动，股价快速上涨5.24%。截至发稿，该股报1.11美元/股，成交量10.516...
08-14 02:12
燃石医学盘中异动 股价大涨5.11%报7.20美元
北京时间2024年08月14日00时21分，燃石医学（BNR.us）股票出现波动，股价大幅上涨5.11%。截至发稿，该股报7.20美元/股，成交量1337股，换...
08-14 00:21
美股周涨跌榜 | 光纤股Lumen大涨81.4%！获50亿美元大单；Upstart业绩超预期周内累涨52.6%
光纤股Lumen大涨81.4%！获50亿美元大单；UpstartQ2业绩超预期，周内累涨52.6%>>
08-10 15:58
女股神新宠：不仅是特斯拉和科技股
Cathie Wood，以大胆投资颠覆性创新企业而名声大噪。2020年，她旗下的ARK创新ETF(NYSE:ARKK)表现强劲，回报率高达150%，一时赢得了广...
08-09 19:32
Why Is Japanese Drugmaker Takeda Pharmaceutical Stock Trading Higher On Wednesday?
Takeda Pharmaceutical stock rises following European Commission approval of Adzynma for treating ADAMTS13 deficiency in cTTP patients. Adzynma is the first enzyme replacement therapy in the EU for this rare blood disorder, demonstrating significant safety and efficacy.
08-08 02:29
